Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kyprolis
Kyprolis
Most Popular News Headlines For Wednesday, August 13 2014
CP Wire
Thu, 08/14/14 - 10:11 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
Most popular news headlines for Wednesday, August 13 2014
Thu, 08/14/14 - 10:09 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal
Motley Fool
Thu, 08/14/14 - 08:43 am
Amgen
Kyprolis
Multiple Myeloma
Amgen Drops in After Hours on Failed Trial, Recall
Barron's
Wed, 08/13/14 - 04:36 pm
Amgen
Kyprolis
recalls
Aranesp
Multiple Myeloma
Amgen reports positive trial of multiple myeloma treatment
Marketwatch
Mon, 08/4/14 - 08:57 am
Amgen
Multiple Myeloma
Kyprolis
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
24/7 Wall St
Mon, 07/28/14 - 12:26 pm
Arrowhead Research
Gilead Sciences
Intercept Pharmaceuticals
Amgen
Vertex Pharmaceuticals
RNAi
Kyprolis
VX-661
Sovaldi
Kalydeco
Will Amgen’s Acquisition of Onyx Pay off Soon?
Motley Fool
Thu, 06/26/14 - 09:36 am
M&A
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
3 Undervalued Amgen Growth Opportunities to Watch
Motley Fool
Mon, 06/16/14 - 09:03 pm
Amgen
evolocumab
Kyprolis
brodalumab
AMG-334
What You Need to Know About Amgen's Oncology Line-Up
Motley Fool
Thu, 01/23/14 - 09:52 am
Amgen
oncology
T-Vec
Kyprolis
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Mon, 11/18/13 - 11:07 am
Multiple Myeloma
Amgen
Kyprolis
Celgene
Array Biopharma Outlines Path To Market For New Myeloma Drug
Forbes
Thu, 10/31/13 - 08:56 am
Multiple Myeloma
Array Biopharma
ARRY-520
Kyprolis
Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thu, 10/24/13 - 09:59 am
Celgene
Multiple Myeloma
Amgen
Kyprolis
Pomalyst
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Mon, 09/30/13 - 10:44 am
Amgen
Takeda
ONYX Pharmaceuticals
Kyprolis
Exclusive: Onyx provides drug trial data to potential bidders - sources
Yahoo/Reuters
Wed, 08/21/13 - 06:58 pm
ONYX Pharmaceuticals
M&A
Amgen
clinical trials
Kyprolis
The Deal: Onyx Trials Cloud Amgen Deal
TheStreet.com
Mon, 08/19/13 - 10:34 pm
ONYX Pharmaceuticals
Amgen
clinical trials
M&A
Kyprolis
Amgen's Focus On Kyprolis Data Shows Need To Aspire
Seeking Alpha
Sat, 08/17/13 - 10:41 am
Amgen
Kyprolis
Onyx
Hemerus Medical M&A
Amgen Talks to Buy Onyx Said to Stall on Drug Trial Data
Bloomberg
Thu, 08/15/13 - 10:40 am
Amgen
ONYX Pharmaceuticals
M&A
Kyprolis
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
FDA Approval and a Trial Failure: Which Is More Important?
Motley Fool
Mon, 07/23/12 - 10:50 pm
FDA
ONYX Pharmaceuticals
Kyprolis
Nexavar
Pages
« first
‹ previous
1
2
3
4
next ›
last »